BioLife Solutions, Inc.
BioLife Solutions, Inc.（BLFS）内幕交易
基于 SEC Form 4 的买入/卖出笔数、买卖比与情绪标签；可在本季度与近12个月之间切换；下方为季度图与交易明细。
SEC EDGAR · FMP · BLFS · 截至 2026年6月8日
活动摘要
买入笔数
0
P-Purchase only
卖出笔数
71
近12个月
买卖比
0.00
Buy/Sell (by trades)
整体情绪
BioLife Solutions, Inc.内部人在过去近12个月主要在卖出股份，卖出行为通常由预设的Rule 10b5-1计划驱动，不一定代表对公司的负面看法。
▸ 数据来源：SEC EDGAR · Form 3 & 4 · 买入仅计P-Purchase · 卖出仅计S-Sale
截至 2026年6月8日
BLFS 季度内部人买卖趋势
BLFS 内幕交易卖出 · BLFS 内幕交易买入 · 季度活动
Mobile shows last 4Q · Desktop shows full 8Q
▸ 数据来源：SEC EDGAR · Form 3 & 4 · 最近8季度
As of Jun 8, 2026
活跃内部人
近12个月交易最活跃 · BLFS CEO内幕交易
显示全部内部人 · 点击卡片过滤下方交易表
▸ 按reportingName聚合 · 近12月交易次数Top5 · 无额外API
近期内幕交易记录
BLFS 高管卖出股份 · BLFS 董事内幕交易 · SEC Form 4申报
横向滑动查看全部列
| 日期 | 内部人 | 类型 | 股数 | 总金额 | 申报 |
|---|---|---|---|---|---|
| Apr 8, 2026 | Mathew Aby J. EVP & Chief Scientific Officer | Other | 515 | $10K | Form 4 |
| Apr 8, 2026 | Berard Todd Chief Marketing Officer | Other | 293 | $6K | Form 4 |
| Apr 8, 2026 | Wichterman Troy CFO | Other | 844 | $16K | Form 4 |
| Mar 23, 2026 | Foster Karen A. Chief Quality and Operations | Sale | 2,577 | $49K | Form 4 |
| Mar 19, 2026 | DE GREEF RODERICK President and CEO · Director | Other | 11,101 | $212K | Form 4 |
| Mar 19, 2026 | Berard Todd Chief Marketing Officer | Other | 1,879 | $36K | Form 4 |
| Mar 19, 2026 | Werner Sean CTO | Other | 1,681 | $32K | Form 4 |
| Mar 19, 2026 | Wichterman Troy CFO | Other | 3,749 | $72K | Form 4 |
| Mar 19, 2026 | Aebersold Sarah Chief Human Resources Officer | Other | 931 | $18K | Form 4 |
| Mar 19, 2026 | Foster Karen A. Chief Quality and Operations | Other | 1,907 | $36K | Form 4 |
| Mar 19, 2026 | Mathew Aby J. EVP & Chief Scientific Officer | Other | 2,255 | $43K | Form 4 |
| Mar 5, 2026 | Foster Karen A. Chief Quality and Operations | Sale | 96,923 | $1.95M⚡ | Form 4 |
| Mar 9, 2026 | Foster Karen A. Chief Quality and Operations | Sale | 500 | $10K | Form 4 |
| Mar 3, 2026 | Werner Sean CTO | Sale | 111 | $2K | Form 4 |
| Mar 3, 2026 | Foster Karen A. Chief Quality and Operations | Sale | 418 | $9K | Form 4 |
| Mar 3, 2026 | Mathew Aby J. EVP & Chief Scientific Officer | Sale | 529 | $11K | Form 4 |
| Mar 3, 2026 | Wichterman Troy CFO | Sale | 588 | $12K | Form 4 |
| Mar 3, 2026 | Aebersold Sarah Chief Human Resources Officer | Sale | 219 | $5K | Form 4 |
| Mar 3, 2026 | Berard Todd Chief Marketing Officer | Sale | 353 | $7K | Form 4 |
| Feb 24, 2026 | Berard Todd Chief Marketing Officer | Award | 22,479 | — | Form 4 |
| Feb 24, 2026 | Berard Todd Chief Marketing Officer | Other | 8,846 | $200K | Form 4 |
| Feb 24, 2026 | Berard Todd Chief Marketing Officer | Award | 20,096 | — | Form 4 |
| Feb 24, 2026 | DuRoss Amy Director | Award | 8,170 | — | Form 4 |
| Feb 24, 2026 | Wichterman Troy CFO | Award | 64,866 | — | Form 4 |
| Feb 24, 2026 | Wichterman Troy CFO | Other | 25,525 | $578K | Form 4 |
DE GREEF RODERICK
President and CEO · Director
日期
Mar 19
股数
11,101
均价
$19.12
总金额
$212K
Foster Karen A.
Chief Quality and Operations
日期
Mar 19
股数
1,907
均价
$19.12
总金额
$36K
Mathew Aby J.
EVP & Chief Scientific Officer
日期
Mar 19
股数
2,255
均价
$19.12
总金额
$43K
Foster Karen A.
Chief Quality and Operations
日期
Mar 5
股数
96,923
均价
$20.15
总金额
$1.95M ⚡
⚡ = 金额≥$100万 · Award/Option价格显示— · 仅Form4 · 仅普通股
▸ 数据来源：SEC EDGAR · Form 4 申报 · ⚡ = 金额≥$100万 · Award/Option 价格显示 —
关于 BLFS 内幕交易
BLFS 内幕交易
BioLife Solutions, Inc.（BLFS）内幕交易数据来源于公司内部人（包括Berard Todd (Chief Marketing Officer), Wichterman Troy (CFO), Foster Karen A. (Chief Quality and Operations)）提交的SEC Form 4申报文件。过去12个月内，5位内部人向SEC提交了交易申报。BLFS内部人近期主要在卖出，这可能反映预设的10b5-1计划执行，而非方向性判断。
如需查看BioLife Solutions, Inc.机构持仓比例和内部人持股百分比，请访问持仓（Ownership）标签页 → Ownership tab →
常见问题
BLFS 内幕交易 · 5个问题BioLife Solutions, Inc.（BLFS）的内部人包括高管和董事，如Berard Todd (Chief Marketing Officer), Wichterman Troy (CFO), Foster Karen A. (Chief Quality and Operations)等。过去12个月内，5位内部人向SEC提交了Form 4交易申报。内部人须在交易日期后2个工作日内完成申报。
▸ 数据来源：FMP /stable/insider-trading/search · SEC EDGAR Form 3 & 4 · RSU归属不计入情绪 · As of Jun 8, 2026